quarter to XX% and everyone, of us. joining Sean, quarter Today you, great Thank another quarter for second we thank the organic XXXX. growth compared you, for Dexcom of reported second revenue with
continues time product CGM than access alone, is company's of our at our broadened XXXX and reimbursed the history. first for faster expanded meaningfully to as Dexcom reach Demand grow CGM. to strategy, coverage extended half for our we geographic portfolio expanding any Dexcom's in product our In
up time company, of the are have our of to year at to a form ease this factor, and faster alike we midpoint consistently GX clinicians As use, GX's sevens for the U.S., excited feedback software lot of be sit we gain launch our warm around Customers discrete great pivotal and momentum. platform. about. sharing redesigned continues In
as and in never has our Dexcom a simplicity. of or and prescribe been terms easier customers performance With use accuracy significant to we've a while are prescribers forward in our a leadership result. extended we position this taking It new product, attracting and to step product CGM, ecosystem
the a GX trend Dexcom. to to of of continuation have new that have majority users the seen we Similar quarter, last our been
prescribing the were efforts. in Additionally, scripts those writing for trends and now that not there hold to Dexcom. validating market U.S We previously prescribing appeal, GX physicians early are designed GX broad X,XXX are these
GX. to continue we the Behind reimbursement scenes for drive
process in pharmacy Dexcom now that As the coverage all first GX. we progressing commercial while quarter advanced quarter, PBMs share expected, second during contracts. our DME broad commercial cover the rapidly this as major a to established we reminder, are We Medicare and and excited further
we than brings leading strengthens most number prioritize line further faster and covered out our low levels. position much CGM pocket This GX occurred customers. is in as originally our our covered anticipated This we with total industry costs lives of nearly for our the of GX brand keeping
are As nearest reminder, which pocket than a per than customers than the month. competitor the a pharmacy out paying less where of our channel, less majority are $XX of our significantly of the majority month is $XX paying customers greater in
insulin a are seeing role important We we broadly for also play as management. intensive very GX more beyond us move
this insulin use. that big decision coverage taken CMS to We've direction in significantly a expand year recent the following intensive step beyond
As insulin only April, in X resulted hypoglycemia. basal who non-insulin officially certain coverage using a kicked have Medicare of for as type industry. true in experienced diabetes This change individuals with the mid coverage as in using step for well people
two being of these estimate, U.S encouraging people been also It populations represent to commercial quickly roughly with half payers we to age. As Medicare follow million X the in see around suit. has X million
XX% We Dexcom's have a which than value view of greater already established as by we coverage proposition population, basal for the validation commercial payers.
this as this quickly us We to as provides flexibility of greater much are coverage thrilled it promote established opportunity. to commercial level have
prescribing has potential in encouraging. a no as patients While wasted been to early, among the response time clear this basal the still outcomes Physicians initial very better from Dexcom their population. recognize community for they clinical have
have engaging of more decisions. We coming data seen also make lifestyle who glucose the directly to basal with are their informed in excitement interested members community from
notable we result, in in Medicare seen a As have uptick business. demand a our
we company. positive sign history Medicare channel quarter In as fact, the was of of expanded come. highest a very our QX view of things a within new was quarter this coverage, partial to patient our only Considering this the in
X our into new quarter initiatives share business, more international people us our globe. diabetes GX our helped In reach strategy expanded accelerated across portfolio have markets. We product the in quarter with our as second international gains and in the ongoing access the launch many second
we we bring it enthusiasm to is received initial countries Canada with to GX met lot and in regulatory geographies excited will clearance. include recently additional This of GX a coming months. where of being launch the are launch into in our our
We have this Malaysia support plenty with facility rollout, product. broader inventory now on our particularly hand producing to commercial of
this international entrance in us serve accelerate for lever Latin entrance reimbursement has proven catalyst new launched ONE has to markets, broaden initial in even noteworthy which for rollout America. most into officially our ONE DexCom our within our been geographies DexCom regions. of broader as key ONE. a Another and certain access into Perhaps that DexCom quarter marks we is Argentina, past existing
global to be for point only in starting to in as expand that years. reach coming this our expect us region a we We continue
evidence came XXrd our Dexcom as to Sessions event the future. Association's Diabetes Finally, growing from as away American the year's we excited ability body of This Scientific to CGM's ever demonstrating added about and drive the outcomes clear economic population intensive a health insulin insulin suggesting together. use diabetes outside greater use the care across continuum, and data all beyond more of we particularly, seeing even are
world CGM engagement important levels. meaningful type improvement a than study and was wore diabetes months, more of and Dexcom as For adults than high-level team Perhaps insulin. as X not just AXc time. demonstrated using were increase clinically this cohort XX% study the with a range of more presented the example, saw who our in real After participants of in XX% X,XXX a time only X
levels including to seen we type CGM X clear a utilization high the we MOBILE with consistent other what This to our full broader trial where saw in studies, Dexcom and time. continue of have was desire
weekend of we shared During Dexcom. our where Day ADA the around hosted Investor future an we latest vision
plan provided custom GX broader provide not software our new increased As specifically LRP, the access tailored launch recent to to of product our people leverage but our detail will shared day insulin. experience we part our a we and on of product the size With for hardware, this population. this a on wins
expect out option. users XX-day case year launch broader next We we pay coverage. build payers of for the gate cash simplify and with This as time to the access with for will early wear a
where Importantly, provides build into and this future utilize to glimpse much expect software also larger to experiences populations. tailored product serve we new our a
just said started. at As we're Investor we Day getting
for review to turn over Jereme? of will second it the With that, financials. quarter Jereme I a
